David Solit

A Big Data Approach To Identifying New Cancer Drug Targets

David Solit

Talk: A Big Data Approach To Identifying New Cancer Drug Targets

Physician-scientist David Solit focuses on the development of cancer therapies that target pathways responsible for cancer initiation and progression. Dr. Solit is the Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO), Memorial Sloan Kettering’s new collaborative center that is undertaking a wide-ranging effort to correlate tumor genetics with clinical outcomes and responses to therapy. He is also a member of the Human Oncology and Pathogenesis Program, where his laboratory team works to identify novel drug targets.

David Solit

Dr. David Solit is the Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO), Memorial Sloan Kettering’s new collaborative center that is undertaking a wide-ranging effort to correlate tumor genetics with clinical outcomes and responses to therapy. He is also a member of the Human Oncology and Pathogenesis Program, where his laboratory team works to identify novel drug targets.